Guided Therapeutics Inc GTHP
We take great care to ensure that the data presented and summarized in this overview for GUIDED THERAPEUTICS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GTHP
Top Purchases
Top Sells
About GTHP
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Insider Transactions at GTHP
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2025
|
Alan Grujic |
BUY
Open market or private purchase
|
Direct |
152,108
+7.72%
|
-
|
|
Aug 29
2025
|
John E Imhoff |
BUY
Open market or private purchase
|
Direct |
166,667
+0.85%
|
$0
$0.18 P/Share
|
|
Aug 29
2025
|
Michael C James |
BUY
Open market or private purchase
|
Direct |
27,778
+4.78%
|
$0
$0.18 P/Share
|
|
Aug 21
2025
|
Alan Grujic |
BUY
Other acquisition or disposition
|
Direct |
217,408
+5.95%
|
-
|
|
Aug 21
2025
|
Alan Grujic |
SELL
Other acquisition or disposition
|
Direct |
50
-100.0%
|
-
|
|
Aug 21
2025
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
1,304,448
+3.21%
|
-
|
|
Aug 21
2025
|
John E Imhoff |
SELL
Other acquisition or disposition
|
Direct |
300
-75.0%
|
-
|
|
Aug 21
2025
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
1,013,121
+5.84%
|
-
|
|
Aug 21
2025
|
Richard P. Blumberg |
SELL
Other acquisition or disposition
|
Direct |
233
-100.0%
|
-
|
|
Apr 10
2025
|
Richard P. Blumberg |
BUY
Other acquisition or disposition
|
Direct |
221,334
+1.58%
|
-
|
|
Apr 10
2025
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
6,365
+0.04%
|
-
|
|
Mar 18
2025
|
John E Imhoff |
BUY
Open market or private purchase
|
Direct |
1,263,069
+3.39%
|
$0
$0.1 P/Share
|
|
Mar 18
2025
|
Michael C James |
BUY
Open market or private purchase
|
Direct |
412,945
+34.84%
|
$0
$0.1 P/Share
|
|
Mar 11
2025
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
2,258,690
+11.9%
|
$0
$0.13 P/Share
|
|
Mar 11
2025
|
John E Imhoff |
SELL
Other acquisition or disposition
|
Direct |
286
-100.0%
|
-
|
|
Mar 07
2025
|
John E Imhoff |
BUY
Open market or private purchase
|
Direct |
286
+50.0%
|
-
|
|
Mar 06
2025
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
5,701,500
+16.72%
|
$0
$0.5 P/Share
|
|
Mar 06
2025
|
John E Imhoff |
SELL
Other acquisition or disposition
|
Direct |
2,400
-100.0%
|
-
|
|
Mar 06
2025
|
John E Imhoff |
SELL
Other acquisition or disposition
|
Direct |
300
-100.0%
|
-
|
|
Jan 17
2025
|
John E Imhoff |
BUY
Other acquisition or disposition
|
Direct |
35,312
+0.4%
|
-
|
Last 12 Months Summary
| Open market or private purchase | 3.64M shares |
|---|---|
| Other acquisition or disposition | 11.2M shares |
| Other acquisition or disposition | 3.57K shares |
|---|